“Small-Molecule PD-L1 Modulators as Alternatives to Checkpoint Antibodies: Implications for Infection-Associated Immune Toxicities”, JISEES, p. 088, Oct. 2025, doi: 10.46991/JISEES.2025.SI1.088.